Literature DB >> 28428273

Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion.

Hsin-Yu Chen1,2,3, Peder E Z Larson1,2,3, Robert A Bok3, Cornelius von Morze3, Renuka Sriram3, Romelyn Delos Santos3, Justin Delos Santos3, Jeremy W Gordon3, Naeim Bahrami3,4, Marcus Ferrone5, John Kurhanewicz1,2,3, Daniel B Vigneron6,2,3.   

Abstract

New magnetic resonance (MR) molecular imaging techniques offer the potential for noninvasive, simultaneous quantification of metabolic and perfusion parameters in tumors. This study applied a three-dimensional dynamic dual-agent hyperpolarized 13C magnetic resonance spectroscopic imaging approach with 13C-pyruvate and 13C-urea to investigate differences in perfusion and metabolism between low- and high-grade tumors in the transgenic adenocarcinoma of mouse prostate (TRAMP) transgenic mouse model of prostate cancer. Dynamic MR data were corrected for T1 relaxation and RF excitation and modeled to provide quantitative measures of pyruvate to lactate flux (kPL ) and urea perfusion (urea AUC) that correlated with TRAMP tumor histologic grade. kPL values were relatively higher for high-grade TRAMP tumors. The increase in kPL flux correlated significantly with higher lactate dehydrogenase activity and mRNA expression of Ldha, Mct1, and Mct4 as well as with more proliferative disease. There was a significant reduction in perfusion in high-grade tumors that associated with increased hypoxia and mRNA expression of Hif1α and Vegf and increased ktrans , attributed to increased blood vessel permeability. In 90% of the high-grade TRAMP tumors, a mismatch in perfusion and metabolism measurements was observed, with low perfusion being associated with increased kPL This perfusion-metabolism mismatch was also associated with metastasis. The molecular imaging approach we developed could be translated to investigate these imaging biomarkers for their diagnostic and prognostic power in future prostate cancer clinical trials. Cancer Res; 77(12); 3207-16. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28428273      PMCID: PMC5484421          DOI: 10.1158/0008-5472.CAN-16-2083

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

Review 1.  Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis.

Authors:  Suveera Dhup; Rajesh Kumar Dadhich; Paolo Ettore Porporato; Pierre Sonveaux
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Imaging of blood flow using hyperpolarized [(13)C]urea in preclinical cancer models.

Authors:  Cornelius von Morze; Peder E Z Larson; Simon Hu; Kayvan Keshari; David M Wilson; Jan Henrik Ardenkjaer-Larsen; Andrei Goga; Robert Bok; John Kurhanewicz; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2011-03       Impact factor: 4.813

3.  A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Authors:  Scott E Eggener; Alex Mueller; Ryan K Berglund; Raj Ayyathurai; Cindy Soloway; Mark S Soloway; Robert Abouassaly; Eric A Klein; Steven J Jones; Chris Zappavigna; Larry Goldenberg; Peter T Scardino; James A Eastham; Bertrand Guillonneau
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

4.  Quantitative measurement of cancer metabolism using stimulated echo hyperpolarized carbon-13 MRS.

Authors:  Christine Leon Swisher; Peder E Z Larson; Klaus Kruttwig; Adam B Kerr; Simon Hu; Robert A Bok; Andrei Goga; John M Pauly; Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2013-02-14       Impact factor: 4.668

5.  Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer.

Authors:  Michael Milosevic; Padraig Warde; Cynthia Ménard; Peter Chung; Ants Toi; Adrian Ishkanian; Michael McLean; Melania Pintilie; Jenna Sykes; Mary Gospodarowicz; Charles Catton; Richard P Hill; Robert Bristow
Journal:  Clin Cancer Res       Date:  2012-03-31       Impact factor: 12.531

6.  Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

Authors:  David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Aaron Charlop; Thomas J Lawton; Erin K Schubert; Jeffrey Tseng; Robert B Livingston
Journal:  J Nucl Med       Date:  2002-04       Impact factor: 10.057

7.  Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.

Authors:  J-M Beauregard; S G Williams; T R Degrado; P Roselt; R J Hicks
Journal:  J Med Imaging Radiat Oncol       Date:  2010-08       Impact factor: 1.735

8.  [Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in prostate cancer and its significance].

Authors:  Liang Wang; Zhao-jie Chen; Qing-tang Wang; Wen-feng Cao; Yi Jian; Sheng-xian Wang; Bing-hong Zhang
Journal:  Zhonghua Nan Ke Xue       Date:  2006-01

9.  Kinetic modeling of hyperpolarized (13)C pyruvate metabolism in tumors using a measured arterial input function.

Authors:  S M Kazan; S Reynolds; A Kennerley; E Wholey; J E Bluff; J Berwick; V J Cunningham; M N Paley; G M Tozer
Journal:  Magn Reson Med       Date:  2012-11-20       Impact factor: 4.668

10.  SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy Workflows.

Authors:  Jason C Crane; Marram P Olson; Sarah J Nelson
Journal:  Int J Biomed Imaging       Date:  2013-07-18
View more
  32 in total

1.  Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer In Vivo Predicts Efficacy of Targeting the Warburg Effect.

Authors:  Bradley T Scroggins; Masayuki Matsuo; Ayla O White; Keita Saito; Jeeva P Munasinghe; Carole Sourbier; Kazutoshi Yamamoto; Vivian Diaz; Yoichi Takakusagi; Kazuhiro Ichikawa; James B Mitchell; Murali C Krishna; Deborah E Citrin
Journal:  Clin Cancer Res       Date:  2018-03-29       Impact factor: 12.531

2.  Coil combination methods for multi-channel hyperpolarized 13C imaging data from human studies.

Authors:  Zihan Zhu; Xucheng Zhu; Michael A Ohliger; Shuyu Tang; Peng Cao; Lucas Carvajal; Adam W Autry; Yan Li; John Kurhanewicz; Susan Chang; Rahul Aggarwal; Pamela Munster; Duan Xu; Peder E Z Larson; Daniel B Vigneron; Jeremy W Gordon
Journal:  J Magn Reson       Date:  2019-02-01       Impact factor: 2.229

3.  Technique development of 3D dynamic CS-EPSI for hyperpolarized 13 C pyruvate MR molecular imaging of human prostate cancer.

Authors:  Hsin-Yu Chen; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; Marcus Ferrone; Mark van Criekinge; Lucas Carvajal; Peng Cao; John M Pauly; Adam B Kerr; Ilwoo Park; James B Slater; Sarah J Nelson; Pamela N Munster; Rahul Aggarwal; John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-03-25       Impact factor: 4.668

4.  Assessing high-intensity focused ultrasound treatment of prostate cancer with hyperpolarized 13 C dual-agent imaging of metabolism and perfusion.

Authors:  Jessie E Lee; Chris J Diederich; Robert Bok; Renuka Sriram; Romelyn Delos Santos; Susan M Noworolski; Vasant A Salgaonkar; Matthew S Adams; Daniel B Vigneron; John Kurhanewicz
Journal:  NMR Biomed       Date:  2018-07-18       Impact factor: 4.044

5.  Simultaneous T1 and T2 mapping of hyperpolarized 13C compounds using the bSSFP sequence.

Authors:  Eugene Milshteyn; Galen D Reed; Jeremy W Gordon; Cornelius von Morze; Peng Cao; Shuyu Tang; Andrew P Leynes; Peder E Z Larson; Daniel B Vigneron
Journal:  J Magn Reson       Date:  2020-02-01       Impact factor: 2.229

6.  Late-stage deuteration of 13C-enriched substrates for T1 prolongation in hyperpolarized 13C MRI.

Authors:  Céline Taglang; David E Korenchan; Cornelius von Morze; Justin Yu; Chloé Najac; Sinan Wang; Joseph E Blecha; Sukumar Subramaniam; Robert Bok; Henry F VanBrocklin; Daniel B Vigneron; Sabrina M Ronen; Renuka Sriram; John Kurhanewicz; David M Wilson; Robert R Flavell
Journal:  Chem Commun (Camb)       Date:  2018-05-17       Impact factor: 6.222

7.  Using bidirectional chemical exchange for improved hyperpolarized [13 C]bicarbonate pH imaging.

Authors:  David E Korenchan; Jeremy W Gordon; Sukumar Subramaniam; Renuka Sriram; Celine Baligand; Mark VanCriekinge; Robert Bok; Daniel B Vigneron; David M Wilson; Peder E Z Larson; John Kurhanewicz; Robert R Flavell
Journal:  Magn Reson Med       Date:  2019-05-03       Impact factor: 4.668

8.  A regional bolus tracking and real-time B1 calibration method for hyperpolarized 13 C MRI.

Authors:  Shuyu Tang; Eugene Milshteyn; Galen Reed; Jeremy Gordon; Robert Bok; Xucheng Zhu; Zihan Zhu; Daniel B Vigneron; Peder E Z Larson
Journal:  Magn Reson Med       Date:  2018-09-18       Impact factor: 4.668

Review 9.  Hyperpolarized 13C MRI: State of the Art and Future Directions.

Authors:  Zhen J Wang; Michael A Ohliger; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; James Slater; Javier E Villanueva-Meyer; Christopher P Hess; John Kurhanewicz; Daniel B Vigneron
Journal:  Radiology       Date:  2019-03-05       Impact factor: 11.105

10.  High spatiotemporal resolution bSSFP imaging of hyperpolarized [1-13 C]pyruvate and [1-13 C]lactate with spectral suppression of alanine and pyruvate-hydrate.

Authors:  Eugene Milshteyn; Cornelius von Morze; Jeremy W Gordon; Zihan Zhu; Peder E Z Larson; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-02-16       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.